Quote | Inhibrx Inc. (NASDAQ:INBX)
Last: | $13.56 |
---|---|
Change Percent: | -0.29% |
Open: | $13.78 |
Close: | $13.56 |
High: | $14.3 |
Low: | $13.33 |
Volume: | 173,880 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Inhibrx Inc. (NASDAQ:INBX)
2024-06-11 17:23:41 ET More on Inhibrx Biosciences, Inc. Inhibrx: Continued Advancement Even After INBRX-101 Sale To Sanofi Financial information for Inhibrx Biosciences, Inc. Read the full article on Seeking Alpha For further details see: Inhibrx Bioscie...
2024-06-07 14:42:51 ET Summary Inhibrx Biosciences, Inc.'s INBRX-109 is a tetravalent drug being developed for the treatment of patients with Ewing Sarcoma and other solid tumor types. It is expected that the Ewing Sarcoma Therapeutics market size could be worth as much as $424.42...
Message Board Posts | Inhibrx Inc. (NASDAQ:INBX)
Subject | By | Source | When |
---|---|---|---|
heres the dolla...boom!! | TrendTrade2016 | investorshub | 01/23/2023 2:14:04 PM |
$INBX DOLLA RUMMER IN PROCESS | TrendTrade2016 | investorshub | 01/23/2023 1:54:04 PM |
INBX...$PRE MARKET VOL | TrendTrade2016 | investorshub | 01/23/2023 12:48:49 PM |
Seems to be dropping | Jaydixson1 | investorshub | 10/20/2022 4:02:27 PM |
Numbers do not make sense. They need to | make it happen | investorshub | 10/04/2022 4:16:35 PM |
News, Short Squeeze, Breakout and More Instantly...
Inhibrx Inc. Company Name:
INBX Stock Symbol:
NASDAQ Market:
Smart Share Global Limited (EM) is expected to report for Q1 2024 American Rebel Holdings Inc. (AREB) is expected to report for Q1 2024 First Republic Bank (San Francisco, California) (FRCB) is expected to report for Q1 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ...
Inhibrx Biosciences Inc. (INBX) is expected to report for Q1 2024
2024-05-31 21:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...